Alleycorp Activity
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Milestone
Portfolio company Thyme Care reached unicorn status ($1B+ valuation), three years after AlleyCorp's initial investment.
Thyme Care
Added recently
3 investments· MAR 2026 – APR 2026Show all
Investment
Led Clarasight's $11.5M Series A for AI-powered enterprise travel and expense management.
Clarasight
Investment
Participated in Portal Space Systems' $50M Series A for advanced spacecraft capabilities.
Portal Space Systems
Investment
Participated in AvoMD's $10M Series A for clinical decision support AI platform.
avoMD
Exit
Portfolio company Transcend Therapeutics acquired by Otsuka Pharmaceutical for $700M upfront (total consideration up to $1.225B).
Transcend Therapeutics
Exit
Portfolio company Wonder ceased operations.
Wonder
Investment
Co-led $23.7M round for Big Health, a digital therapeutics provider with FDA-cleared insomnia and anxiety treatments.
Big Health
Milestone
Portfolio company Chamber Cardio announced $60M Series B funding round.
Chamber Cardio
3 investments· SEP 2025 – JAN 2026Show all
Investment
Led $6M seed round for PraxisPro, an AI sales coaching platform for medical and pharmaceutical sales teams.
PraxisPro
Investment
Led Appetronix's $10M+ seed round with the Grote Family to scale robotic kitchen technology.
Appetronix
Investment
Led $20M Series A for Birches Health, addressing gambling addiction treatment and prevention.
Birches Health
Team Change
Hired Alexi Nazem as General Partner to lead the healthcare investment portfolio.
Alexi Nazem joined as General Partner